3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The U1 small nuclear ribonucleoprotein 70 kDa (U1-70K) and other RNA-binding proteins (RBPs) are mislocalized to cytoplasmic neurofibrillary Tau aggregates in Alzheimer's disease (AD), yet the co-aggregation mechanisms are incompletely understood. U1-70K harbors two disordered low–complexity domains (LC1 and LC2) that are necessary for aggregation in AD brain extracts. The LC1 domain contains highly repetitive basic (Arg/Lys) and acidic (Asp/Glu) residues, referred to as a basic-acidic dipeptide (BAD) domain. We report here that this domain shares many of the properties of the Gln/Asn-rich LC domains in RBPs that also aggregate in neurodegenerative disease. These properties included self-assembly into oligomers and localization to nuclear granules. Co-immunoprecipitations of recombinant U1-70K and deletions lacking the LC domain(s) followed by quantitative proteomic analyses were used to resolve functional classes of U1-70K-interacting proteins that depend on the BAD domain for their interaction. Within this interaction network, we identified a class of RBPs with BAD domains nearly identical to that found in U1-70K. Two members of this class, LUC7L3 and RBM25, required their respective BAD domains for reciprocal interactions with U1-70K and nuclear granule localization. Strikingly, a significant proportion of RBPs with BAD domains had elevated insolubility in the AD brain proteome. Furthermore, we show that the BAD domain of U1-70K can interact with Tau from AD brains but not from other tauopathies. These findings highlight a mechanistic role for BAD domains in stabilizing RBP interactions and in potentially mediating co-aggregation with the pathological AD–specific Tau isoforms.

          Related collections

          Author and article information

          Journal
          J Biol Chem
          J. Biol. Chem
          jbc
          jbc
          JBC
          The Journal of Biological Chemistry
          American Society for Biochemistry and Molecular Biology (11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A. )
          0021-9258
          1083-351X
          13 July 2018
          25 May 2018
          : 293
          : 28
          : 11047-11066
          Affiliations
          From the Departments of []Biochemistry,
          []Neurology, and
          []Pathology and Laboratory Medicine and
          the [§ ]Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322
          Author notes
          [3 ] Supported in part by the Alzheimer's Association (ALZ), Alzheimer's Research UK (ARUK), The Michael J. Fox Foundation for Parkinson's Research (MJFF), and the Weston Brain Institute Biomarkers Across Neurodegenerative Diseases Grant 11060. To whom correspondence should be addressed: Dept. of Biochemistry, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322. Tel.: 404-712-9783; E-mail: nseyfri@ 123456emory.edu .
          [1]

          Supported by Pre-doctoral NINDS Training Grant T32NS007480 and individual NRSA Grant F31NS093859 from the National Institutes of Health.

          [2]

          Supported by National Institutes of Health Training Program in Biochemistry, Cell and Developmental Biology Grant T32GM008367.

          Edited by Paul E. Fraser

          Article
          PMC6052236 PMC6052236 6052236 RA118.001747
          10.1074/jbc.RA118.001747
          6052236
          29802200
          88c29894-87e4-4967-b650-621a4569f9b2
          © 2018 Bishof et al.

          Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.

          History
          : 4 January 2018
          : 23 May 2018
          Funding
          Funded by: HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) , open-funder-registry 10.13039/100000065;
          Award ID: F31NS093859
          Award ID: 3T32NS007480
          Award ID: P30NS055077
          Funded by: Alzheimer's Association , open-funder-registry 10.13039/100000957;
          Award ID: 11060
          Funded by: HHS | NIH | National Institute on Aging (NIA) , open-funder-registry 10.13039/100000049;
          Award ID: P50AG025688
          Award ID: U01AG046161
          Award ID: R21AG054206
          Award ID: 5R01AG053960
          Funded by: National Institute of General Medical Sciences , open-funder-registry 10.13039/100000057;
          Award ID: T32GM008367
          Categories
          Molecular Bases of Disease

          RNA processing,intrinsically disordered protein,RNA-binding protein,proteomics,mass spectrometry (MS),protein–protein interaction,protein aggregation,systems biology,Tau protein (Tau),neurodegeneration

          Comments

          Comment on this article